Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  (1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine hydrochloride

(1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine hydrochloride

Basic information Safety Supplier Related

(1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine hydrochloride Basic information

Product Name:
(1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine hydrochloride
Synonyms:
  • (1R,2S)-2-(3,4-difluorophenyl)cyclopropanaMine Hydrochloride(1:1)
  • (1R,2S)-2-(3,4-Difluorophenyl)-cyclopropan-1-aMine HCL
  • (1R trans)-2-(3,4-difluorophenyl)cyclopropane aMine hydrochloride
  • (1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanami
  • 2-(3,4-Difluoro-phenyl)-cyclopropylamine
  • (1R trans)-2-(3,4-difluorophenyl)cyclopropane amine
  • (1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride
  • CYCLOPROPANAMINE, 2-(3,4-DIFLUOROPHENYL)-, HYDROCHLORIDE (1:1), (1R,2S)-REL-
CAS:
1156491-10-9
MF:
C9H10ClF2N
MW:
205.63
EINECS:
829-852-9
Product Categories:
  • Intermediate of Ticagrelor
  • 1156491-10-9
Mol File:
1156491-10-9.mol
More
Less

(1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine hydrochloride Chemical Properties

Melting point:
>172°C (dec.)
storage temp. 
Inert atmosphere,Store in freezer, under -20°C
solubility 
DMSO (Slightly), Methanol (Slightly)
form 
Solid
color 
White
InChI
InChI=1/C9H9F2N.ClH/c10-7-2-1-5(3-8(7)11)6-4-9(6)12;/h1-3,6,9H,4,12H2;1H/t6-,9+;/s3
InChIKey
IMYLOCHFFLYHPS-RHUSADAZNA-N
SMILES
N[C@@H]1C[C@H]1C1C=CC(F)=C(F)C=1.Cl |&1:1,3,r|
More
Less

(1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine hydrochloride Usage And Synthesis

Uses

(1S,2R)-2-(3,4-Difluorophenyl)-cyclopropanamine is an intermediate used to prepare ticagrelor (T437700).

Synthesis Reference(s)

Synthesis of 2-(3,4-difluorophenyl)cyclopropanamine derivatives and salts. EU Patent EP2644590A1

Synthesis

1,2-Difluorobenzene is reacted with 3-chloropropionyl chloride to produce 3-chloro-1-(3',4'-difluorophenyl)-propan-1-one, which is by addition of N,N-dimethylformamide, phloroglucinol and sodium iodide in the next step converted to 1-(3',4'-difluorophenyl)-3-nitro-propan-1-one. The keto group of the latter intermediate is in the subsequent step stereochemically reduced to hydroxyl group by the use of chiral oxazaborolidine together with borane dimethyl sulfide or borane-N,N-diethyl aniline complex in the presence of tetrahydrofurane. The obtained (1R)-1-(3',4'-difluorophenyl)-3-nitro-propan-1-ol is then added to a mixture of triphenylphosphine and diethylazodicarboxylate in benzene to yield (1S,2R)-2-(3',4'-difluorophenyl)-1-nitrocyclopropane, which is in the last step converted to 2-(3,4-difluorophenyl)cyclopropane amine by reduction of the nitro group by catalytic hydrogenation with palladium catalyst and zink dust. 

(1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine hydrochlorideSupplier

Jiangsu Vcare PharmaTech Co., Ltd. Gold
Tel
13327700685
Email
sales@vcarepharmatech.com
Shanghai Shanyuan pharmaceutical technology co., LTD Gold
Tel
021-31761238 13167072949
Email
3146446224@qq.com
iangsu U-Liy Biotech Pharmaceuticals Inc Gold
Tel
18021412923
Email
1515809609@qq.com
Xi'an Sunriver Biotech Ltd. Gold
Tel
13991954170
Email
info@sunriverbio.com
BeiJing Hwrk Chemicals Limted
Tel
0757-86329057 18934348241
Email
sales4.gd@hwrkchemical.com